The European Medicines Agency (EMA) has approved Johnson & Johnson’s Covid-19 vaccine, making it the fourth vaccine to be approved for delivery to the European Union and its 27 member countries.
EMA has previously approved three Covid-19 vaccines from producers Pfizer, Moderna and AstraZeneca.
Emer Cooke, managing director at EMA, said, “With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens.”
The EMA reports that a worldwide J&J study of 44,000 participants reported the vaccine is 67 percent effective with only a single dose, which would allow for faster vaccination.
J&J is also currently seeking emergency approval in the UK and from the World Health Organization.